Norden Group’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$529K Sell
2,754
-286
-9% -$46.5K 0.04% 353
2026
Q2
$415K Buy
3,040
+421
+16% +$51.7K 0.03% 437
2026
Q1
$309K Sell
2,619
-1,493
-36% -$209K 0.03% 462
2025
Q4
$674K Buy
4,112
+1,744
+74% +$273K 0.07% 275
2025
Q3
$317K Buy
+2,368
New +$288K 0.03% 457
2025
Q2
– Sell
-2,549
Closed -$324K – 581
2025
Q1
$324K Sell
2,549
-1,149
-31% -$177K 0.04% 405
2024
Q4
$532K Buy
3,698
+341
+10% +$48.9K 0.06% 316
2024
Q3
$500K Sell
3,357
-573
-15% -$82.2K 0.06% 319
2024
Q2
$495K Buy
3,930
+958
+32% +$150K 0.1% 217
2024
Q1
$547K Buy
2,972
+830
+39% +$158K 0.11% 211
2023
Q4
$385K Buy
2,142
+749
+54% +$117K 0.07% 167
2023
Q3
$222K Buy
+1,393
New +$228K 0.07% 226

Other funds holding RGEN

Norden Group's RGEN Position: Q3 2026 in Review

Norden Group reduced its Repligen (RGEN) stake by 9.4% in Q3 2026, selling an estimated $46.5K and leaving 2,754 shares worth $529K. The position accounts for 0.04% of the portfolio, ranked #353.

Norden Group first reported a position in RGEN in Q3 2023 and has held it in 12 quarters since. The position peaked at $674K in Q4 2025. 403 funds tracked by Wall St. Rank hold RGEN as of Q3 2026.

  • Norden Group held 2,754 shares of Repligen worth $529K as of Q3 2026.
  • Norden Group sold 286 Repligen shares in Q3 2026, an estimated $46.5K.
  • Repligen made up 0.04% of Norden Group's portfolio in Q3 2026, its #353 holding.
  • Norden Group first reported a position in Repligen in Q3 2023 and has held it in 12 quarters since.
  • Norden Group's Repligen position peaked at $674K in Q4 2025.
  • 403 funds tracked by Wall St. Rank held Repligen as of Q3 2026.

Based on Norden Group's 13F filing for Q3 2026, filed 20 Oct 2026.